Pwodwi: 6-Chloro-3-methyluracil
CAS NO.: 4318-56-3
EINECS nimewo: 610-113-2
Fòmil molekilè: C5H5ClN2O2
Pwa molekilè: 160.55
Pite:98%
Application of 6-Chloro-3-methyluracil :Alogliptin entèmedyè
Anbalaj of 6-Chloro-3-methyluracil:25kg / sak
Lòt non 6-Chloro-3-methyluracil:
6-Chloro-3-methylpyrimidine-2,4(1H,3H)-dyon |
T6MVNVJ C1 FG |
6-chloro-3-methyl-1H-pirimidin-2,4-dyon |
6-chloro-3-metiuracil |
6-Chloro-3-methyl-2,4(1H,3H)-pirimidinedyon |
MFCD01074837 |
6-Chloro-3-methyluracil |
511456 |
2,4(1H,3H)-pirimidinedyon, 6-chloro-3-methyl- |
6-Chloro-3-dimethyl uracil |
Q1:Ki fòs konpayi ou a?
A1: Nou gen plis pase 20 ane eksperyans nan endistri chimik. Avèk faktori bon koperasyon e nou gen sistèm kontwòl kalite strik.
K: Ki jan ou trete plent kalite?
A: Nou gen Pwosedi pou trete plent kliyan yo, sa a:
1.1The sales department is responsible for the collection of customer complaint information and the handling of customer complaints due to non-intrinsic quality of the product; The collected complaint information shall be transmitted to the quality control department in a timely manner. The quality management department is responsible for the handling of product quality complaints. The handlers should have rich professional knowledge and work experience and be able to objectively evaluate customers’ opinions.
1.2 Tout kòmantè kliyan yo dwe voye san pèdi tan bay moun k ap okipe plent kliyan an, epi pèsonn pa dwe okipe yo san otorizasyon.
1.3Lè yo resevwa yon plent kliyan, moun k ap okipe a dwe imedyatman chèche konnen kòz plent lan, evalye li, detèmine nati ak kalite pwoblèm nan, epi pran mezi alè pou fè fas ak li.
1.4 Lè reponn a kliyan, opinyon yo pwosesis yo ta dwe klè, lang oswa ton yo ta dwe modere, pou kliyan konprann ak fasil yo aksepte kòm prensip la.
2Depoze dosye plent kliyan yo
2.1 Tout plent kliyan yo ta dwe anrejistre nan fòm ekri, ki gen ladan non pwodwi, nimewo pakèt, dat plent, metòd plent, rezon plent, mezi tretman, rezilta tretman, elatriye.
2.2 Kenbe analiz tandans nan plent kliyan yo. Si gen nenpòt tandans negatif, idantifye kòz rasin yo epi pran aksyon korektif ki apwopriye yo.
2.3 Dosye plent kliyan yo ak lòt enfòmasyon enpòtan yo dwe ranpli epi kenbe.
Li Dènye Nouvèl Nou yo

Aug.08,2025
The Role of Isoflurane in Low-Flow Anesthesia Systems
Isoflurane, a halogenated ether compound, has maintained its position as a workhorse agent in modern anesthesia practice, particularly in low-flow delivery systems.
Li piplis
Aug.08,2025
Synthesis of Heterocyclic Compounds Using 1,3-Dimethylurea: Expanding Horizons in Pharmaceutical Intermediates Production
The pharmaceutical industry continues to discover innovative applications for 1,3-dimethylurea as a versatile building block in heterocyclic compound synthesis.
Li piplis
Aug.08,2025
Sevoflurane Mechanism of Action in the Brain: Unraveling the Molecular Pathways
Sevoflurane, a fluorinated methyl isopropyl ether, has become one of the most widely used inhalation anesthetics in modern medical practice, with its active pharmaceutical ingredient specifically designed to target neural circuits.
Li piplis